ReviewPharmaceuticals (Basel, Switzerland)2026
Clinical Applications and Evidence Landscape of Thymosin Alpha 1 as an Immunomodulatory Adjunct in Cancer Care: A Scoping Review.
Soo-Dam Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.